These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 21618689
1. Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence. Ghabril M, Dickson RC, Krishna M, Machicao V, Aranda-Michel J, Bonatti H, Nguyen JH. Liver Transpl; 2011 Jun; 17(6):685-94. PubMed ID: 21618689 [Abstract] [Full Text] [Related]
2. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection. Berres ML, Trautwein C, Schmeding M, Eurich D, Tacke F, Bahra M, Neuhaus P, Neumann UP, Wasmuth HE. Hepatology; 2011 Feb; 53(2):596-603. PubMed ID: 21274880 [Abstract] [Full Text] [Related]
3. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Yilmaz N, Shiffman ML, Stravitz RT, Sterling RK, Luketic VA, Sanyal AJ, Mills AS, Contos MJ, Coterell A, Maluf D, Posner MP, Fisher RA. Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360 [Abstract] [Full Text] [Related]
4. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection. Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, Reed AI, Hemming AW, Liu C, Crawford JM, Nelson DR. Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304 [Abstract] [Full Text] [Related]
5. Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Ward SC, Schiano TD, Thung SN, Fiel MI. Liver Transpl; 2009 Dec; 15(12):1826-33. PubMed ID: 19938116 [Abstract] [Full Text] [Related]
13. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients. Khettry U, Huang WY, Simpson MA, Pomfret EA, Pomposelli JJ, Lewis WD, Jenkins RL, Gordon FD. Hum Pathol; 2007 Mar; 38(3):443-52. PubMed ID: 17188331 [Abstract] [Full Text] [Related]
14. Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation. Guillaud O, Gurram KC, Puglia M, Lilly L, Adeyi O, Renner EL, Selzner N. Transplant Proc; 2013 Mar; 45(6):2331-6. PubMed ID: 23953545 [Abstract] [Full Text] [Related]